ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy | Dana-Farber Cancer Institute / Jun Qi, PhD | Innovation Grants | 2019 | Massachusetts |
Enhancing Communication about Sexual and Reproductive Health between Oncology Clinicians and Adolescent and Young Adults | Connecticut Children’s Medical Center / Dr. Natasha Frederick, PhD | Psychosocial Launch Grant | 2018 | Connecticut |
Functional Dissection of Oncogenic Enhancers in T-ALL | Columbia University / Daniel Herranz, PhD | Young Investigator Grants | 2015 | New York |
Columbia University Developmental Therapeutics Program: Striving for Excellence | Columbia University / Julia Glade Bender, MD | Phase I/II Infrastructure Grants | 2013 | New York |
Targeting CCAAT/enhancer binding proteins CEBPB and CEBPD in neuroblastoma | Columbia University / Darrell Yamashiro, MD/PhD | Innovation Grants | 2021 | New York |
Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL. | Columbia University / Teresa Palomero, PhD | Young Investigator Grants | 2007 | New York |
A New York Based Pediatric Oncology Developmental Therapeutics Program | Columbia University / Julia Glade Bender, MD | Phase I/II Infrastructure Grants | 2008 | New York |
Targeting Metabolic Vulnerabilities in ETP-ALL | Columbia University / Adolfo A. Ferrando, MD/PhD | Innovation Grants | 2017 | New York |
Mechanisms and Targeted Inhibition of NT5C2 Mutations in Relapsed ALL | Columbia University / Adolfo A. Ferrando, M.D., Ph.D. | Innovation Grants | 2014 | New York |
Platform development for target identification in high risk pediatric leukemias | Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD | Crazy 8 Pilots | 2019 | New York |